IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673,464 | -29.3% | 148,014 | +9.5% | 0.00% | -50.0% |
| Q2 2023 | $951,901 | +42.4% | 135,162 | +23.6% | 0.00% | 0.0% |
| Q1 2023 | $668,256 | +57.7% | 109,371 | +64.9% | 0.00% | +100.0% |
| Q4 2022 | $423,875 | -33.2% | 66,334 | +0.1% | 0.00% | -50.0% |
| Q3 2022 | $635,000 | +22.1% | 66,278 | +40.6% | 0.00% | +100.0% |
| Q2 2022 | $520,000 | -35.8% | 47,139 | -48.5% | 0.00% | -85.7% |
| Q4 2018 | $810,000 | +34.8% | 91,506 | +71.3% | 0.01% | +75.0% |
| Q3 2018 | $601,000 | – | 53,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |